A Word About May

1 August 2013 In Allies & Partnerships

We just wanted to take a minute and give some long-overdue thanks to the fabulous corporate allies who helped us run a successful Melanoma Awareness Month back in May!  Through online and in-store efforts, the allies helped raise funds for MRA’s scientific research programs and also increased awareness of...

Read More


Learn from my sunscreen mistakes

3 July 2013

Here goes my shameful confession: I work for the Melanoma Research Alliance and I still got a sunburn.  Everyone makes mistakes at a new job, but mine were entirely preventable.

Read More


Melanoma Research Alliance Rings Closing Bell at the New York Stock Exchange

26 June 2013 In Events

[youtube url=http://www.youtube.com/watch?v=_Emq_T2GO5Y] We had a fabulous visibility opportunity yesterday: The Melanoma Research Alliance (MRA) rang the closing bell on the NYSE trading floor on Tuesday, June 25.  Surrounded by MRA leadership and supporters, MRA Co-Founder and Chair Debra Black presided over the ceremony, which signaled the end of the day’s trading.

Read More


Changing Perceptions and Building a Business on Safe Sun: Guest Post by Mott 50

By Monique Moore, Co-Founder, Mott 50 | 20 June 2013 In Allies & Partnerships

Mott 50 Co-Founders Anne Botica Reilly and Monique Moore[/caption] This summer Mott 50 is introducing the Pale is Pretty campaign— a social awareness initiative designed to encourage people to think critically about their sun safety practices and pledge to ‘Practice Safe Sun.’ Our mission at Mott 50 is to...

Read More


A Teenager’s View: Keeping Sun Fun and Avoiding Melanoma

By Langley Grace Wallace | 14 June 2013 In Melanoma Stories

By Langley Grace Wallace Over the past 40 years, melanoma has increased 800% in young women and 400% in young men. Recently, melanoma has become the most common cancer among 25-29 year olds, and even teenagers are developing this deadly skin cancer.

Read More


Two MRA-Sponsored Investigators Published Papers in the New England Journal of Medicine

12 June 2013 In News

Two MRA-sponsored investigators recently reported on the clinical testing of immune checkpoint inhibitors targeting a pathway known as PD-1 in the New England Journal of Medicine. This therapeutic approach, whose clinical utility was established by the FDA approval of ipilimumab in 2011, has produced promising data in patients with advanced melanoma.

Read More


New Melanoma Therapies Approved

31 May 2013 In News

These are the best types of posts to write:  On Wednesday, the US Food and Drug Administration (FDA) approved two genetically-targeted melanoma therapies as well as a companion diagnostic test that will be used to determine which patients' tumors carry the specific genetic mutations the treatments target.

Read More


Safe Sun Style: Guest Post from Meg of SPF Love

30 May 2013 In Allies & Partnerships

It's a common misconception that sun safety is not fashion-forward.  Our guest blogger and May ally SPF Love begs to differ. [caption id="attachment_203" align="aligncenter" width="300"] Meg of SPF Love[/caption] I'm honored to be guest blogging for MRA.  I started my journey over a year ago when I decided to start...

Read More


MRA & Leveraged Finance Fights Melanoma Video Series

19 May 2013 In Events

[brightcove vid=2372187009001&exp3=1405557362001&surl=http://c.brightcove.com/services&pubid=1405556719001&pk=AQ~~,AAABR0G1fZk~,HNsXz5NC104V7oLZ6aVapLmHmSUC2yKF&w=480&h=270] MRA is holding its 2nd annual Leveraged Finance Fights Melanoma event next week in NYC.  Our friends at Privcap produced a series of videos featuring people from the leveraged finance community who have been touched by melanoma.

Read More


Login

×